• 1. Excitation energies from ground-state density-functionals by means of generator coordinates
  A. B. F. da Silva,K. Capelle Phys. Chem. Chem. Phys., 2009,11, 4564-4569
• 2. Distinction of trans–cis photoisomers with comparable optical properties in multiple-state photochromic systems – examining a molecule with three azobenzenes via in situ irradiation NMR spectroscopy?
  Jonas Kind,Lukas Kaltschnee,Martin Leyendecker,Christina M. Thiele Chem. Commun., 2016,52, 12506-12509
• 3. Estimating and correcting interference fringes in infrared spectra in infrared hyperspectral imaging
  Ghazal Azarfar,Ebrahim Aboualizadeh,Nicholas M. Walter,Simona Ratti,Camilla Olivieri,Alessandra Norici,Michael Nasse,Achim Kohler,Mario Giordano Analyst, 2018,143, 4674-4683
• 4. Fe3O4 nanoparticle chains with N-doped carbon coating: magnetotactic bacteria assisted synthesis and high-rate lithium storage?
  Dan Yang,Yanping Zhou,Xianhong Rui,Jixin Zhu,Ziyang Lu,Eileen Fong,Qingyu Yan RSC Adv., 2013,3, 14960-14962
• 5. Excimer and exciplex formation in a pair of bright phosphorescent isomers constructed from Cu3(pyrazolate)3 and Cu3I3 coordination luminophores?
  Shun-Ze Zhan,Mian Li,Xiao-Ping Zhou,Dan Li,Seik Weng Ng RSC Adv., 2011,1, 1457-1459

• Solvents and Organic Chemicals Organic Compounds Acids/Esters

b-NADH Disodium Salt (CAS No: 606-68-8) in Modern Biochemical Research and Therapeutic Applications

The compound b-NADH Disodium Salt, identified by the Chemical Abstracts Service Number (CAS No) 606-68-8, is a critical cofactor in numerous biochemical processes, playing a pivotal role in cellular energy metabolism. This compound, chemically known as sodium salt of β-nicotinamide adenine dinucleotide reduced form, is widely utilized in both academic research and industrial applications due to its unique properties and versatility. Thedisodium salt formulation enhances its solubility and stability, making it an ideal candidate for various biochemical assays and therapeutic interventions.

In recent years, the significance of b-NADH Disodium Salt has been underscored by its involvement in cutting-edge research aimed at understanding and mitigating age-related decline. Nicotinamide adenine dinucleotide (NAD+) is a vital coenzyme found in all living cells, participating in redox reactions and serving as a substrate for enzymes involved in energy production. The reduced form, NADH, is particularly crucial for maintaining cellular homeostasis. Studies have demonstrated that NADH levels decline with age, contributing to mitochondrial dysfunction and oxidative stress. This has spurred interest in the development of strategies to replenish NAD+ pools, with b-NADH Disodium Salt emerging as a promising tool.

Thedisodium salt form of NADH offers several advantages over other formulations. Its enhanced solubility in aqueous solutions facilitates easier incorporation into experimental systems, while its stability under various conditions ensures reliable results. These properties make it an invaluable resource for researchers studying metabolic pathways, mitochondrial health, and neuroprotective mechanisms. Furthermore, the use of b-NADH Disodium Salt has been explored in preclinical models investigating the potential benefits of NADH supplementation in combating neurodegenerative disorders such as Alzheimer's disease and Parkinson's disease.

Recent advancements in biotechnology have enabled the development of novel delivery systems for b-NADH Disodium Salt, enhancing its bioavailability and therapeutic efficacy. Liposomal encapsulation and nanotechnology-based approaches have shown promise in delivering NADH directly to target tissues, thereby optimizing its pharmacological effects. These innovations are particularly relevant in the context of treating chronic diseases where sustained intracellular levels of NAD+ are essential.

The role of b-NADH Disodium Salt extends beyond basic research; it has significant implications for therapeutic applications. In the field of anti-aging medicine, NADH supplementation has been proposed as a means to counteract age-related decline by restoring mitochondrial function and reducing oxidative damage. Clinical trials are ongoing to evaluate the efficacy of NADH-based therapies in improving cognitive function, muscle performance, and overall vitality. Additionally, the compound has been investigated for its potential role in managing metabolic disorders such as diabetes and obesity by enhancing insulin sensitivity and energy expenditure.

Thedisodium salt formulation of b-NADH offers distinct advantages over other forms due to its superior solubility and stability. These characteristics make it an ideal candidate for use in high-throughput screening assays and large-scale biochemical studies. Researchers have leveraged these properties to develop novel enzymatic assays and redox-based sensors that rely on precise concentrations of NADH for accurate measurements. Such tools are essential for unraveling complex biological pathways and identifying new drug targets.

In conclusion, b-NADH Disodium Salt (CAS No: 606-68-8) represents a cornerstone compound in modern biochemical research and therapeutic development. Its multifaceted roles in energy metabolism, cellular signaling, and disease mitigation underscore its importance as a research tool and potential therapeutic agent. As our understanding of NAD+ biology continues to evolve, the applications of thisdisodium salt formulation are expected to expand further, opening new avenues for treating a wide range of health conditions.

• 146-78-1(2-Fluoroadenosine)
• 53-59-8(NADP)
• 60-92-4(Cyclic AMP)
• 86-08-8(3-Acetylpyridine adenine dinucleotide)
• 68141-45-7(b-Nicotinamide adenine dinucleotide phosphate potassium salt hydrate)
• 56-65-5(Adenosine 5'-Triphosphate)
• 61-19-8(Adenosine monophosphate)
• 53-84-9(b-Nicotinamide Adenine Dinucleotide)
• 58-61-7(Adenosine)
• 7298-93-3(β-D-Xylofuranose, 1-(6-amino-9H-purin-9-yl)-1-deoxy-, inner salt, 5-[3-(aminocarbonyl)-1-[5-O-[hydroxy(phosphonooxy)phosphinyl]-α-D-ribofuranosyl]pyridiniumyl])